Home/Filings/4/0001698998-25-000001
4//SEC Filing

Woolson Daniel 4

Accession 0001698998-25-000001

CIK 0000883984other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 7:52 PM ET

Size

15.3 KB

Accession

0001698998-25-000001

Insider Transaction Report

Form 4
Period: 2025-03-07
Woolson Daniel
VP, GM-Infusion Capital
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-07+96611,832 total
  • Exercise/Conversion

    Common Stock

    2025-03-079660 total
    Exercise: $0.00From: 2023-03-07Exp: 2025-03-07Common Stock (966 underlying)
  • Tax Payment

    Common Stock

    2025-03-07$141.97/sh467$66,30011,365 total
  • Exercise/Conversion

    Common Stock

    2025-03-08+2,15313,518 total
  • Tax Payment

    Common Stock

    2025-03-08$141.97/sh953$135,29712,565 total
  • Award

    Common Stock

    2025-03-07+4,75511,214 total
    Common Stock (4,755 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-082,1539,061 total
    Common Stock (2,153 underlying)
Footnotes (4)
  • [F1]These securities are Restricted Stock Units.
  • [F2]There is neither a purchase price nor an exercise price for the Restricted Stock Units.
  • [F3]One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
  • [F4]These are restricted stock units that fully vest 3 years from the grant date.

Issuer

ICU MEDICAL INC/DE

CIK 0000883984

Entity typeother

Related Parties

1
  • filerCIK 0001698998

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 7:52 PM ET
Size
15.3 KB